Search results - 56 results
COVID-19 vaccine effectiveness against symptomatic infection and hospitalisation in Belgium, July 2021 to May 2022.
used a test-negative design and proportional hazard regression to estimate VE i and VE h, controlling for prior infection, time since vaccination, age, sex, residence and calendar week of ...
Characterization of a Bacteriophage GEC_vB_Bfr_UZM3 Active against.
GEC_vB_Bfr_UZM3 (UZM3), which was used for the treatment of a patient with a chronic osteomyelitis caused by a mixed infection. Studied biological and morphological properties of UZM3 showed that it seems to ...
Homologous versus heterologous prime-boost COVID-19 vaccination: impact on clinical severity of Omicron among hospitalized COVID-19 patients in Belgium
among hospitalized COVID-19 patients offered by the contrasted prime-boost vaccination schemes. These results can inform vaccine policy, and contribute to knowledge used for the development of strategies ...
The analysis of cannabinoids in e-cigarette liquids using LC-HRAM-MS and LC-UV
(2023) Keywords: Cannabinoids CBD-liquids e-cigarettes LC-HRAM-MS Abstract: The use of cannabidiol or CBD products has skyrocketed in the last five years due to the alleged therapeutic benefits, a low ...
The GEONs API-fingerprint program: Tackling falsifications of APIs
Official Medicines Control Laboratory (OMCL) Network (GEON) different initiatives were taken to augment the analysis and market surveillance of API s used by the different manufacturers. Despite the efforts, ...
Investigating COVID-19 Vaccine Impact on the Risk of Hospitalisation through the Analysis of National Surveillance Data Collected in Belgium.
vaccination campaign against SARS-CoV-2 started in January 2021 in Belgium. In the present study, we aimed to use national hospitalisation surveillance data to investigate the recent evolution of vaccine impact ...
Vaccine effectiveness against onward transmission of SARS-CoV2-infection by variant of concern and time since vaccination, Belgian contact tracing, 2021.
infectiousness of breakthrough cases (VE i) for a complete schedule of Ad26. COV2.S, ChAdOx1, BNT162 b2, mRNA-1273 as well as infection-acquired and hybrid immunity. We used a multilevel Bayesian model and ...
Incidence and Risk Factors of COVID-19 Vaccine Breakthrough Infections: A Prospective Cohort Study in Belgium.
associated with breakthrough infections were analyzed using COX proportional hazard models. Among 8,062,600 fully vaccinated adults, we identified 373,070 breakthrough infections with an incidence of 11.2 (95% ...
Controlled Human Infection Studies: Proposals for guidance on how to design, develop and produce a challenge strain.
followed by use of qualified methods to test critical steps in the manufacturing process, or the final product itself. These activities are complementary: GMP rules, which intervene only at the time of the ...
The Importance of Quality Control of LSDV Live Attenuated Vaccines for Its Safe Application in the Field.
also suggestive for the presence of GTPV- LSDV (vaccine/wild) recombinants. In addition, the LSDV status of some of the animal samples was greatly influenced by the differentiating real- PCR used and ...